Merck & Co., Inc.
MRK US
MRK USMerck & Co., Inc.
USFIGI: BBG000BPD168
Merck Gets FDA Priority Review for New Keytruda Cervical Cancer Indication >MRK
Merck Gets FDA Priority Review of Welireg in Advanced Renal Cell Carcinoma >MRK
New Cancer Drugs Are Changing the Odds. The Latest on Treatments.
Dow Jones Dives As Disney Gets Huge Bid; Fed Meet Looms
Merck Gets CHMP Backing for Keytruda as Non-Small Cell Lung Cancer Adjuvant >MRK
'This Is Not a Covid Vaccine Company,' Moderna CEO Says
Moderna Surges After Flu Shot Beats Out Widely Used Sanofi, GSK Vaccines
These four Dow stocks take top prizes for dividend growth
Big Pharma’s Battle With the Biden Administration Could Have Legs
These four Dow stocks take top prizes for dividend growth
Portage Biotech Shares Rise 20% After Keytruda Deal With Merck
Portage Biotech in Keytruda Collaboration With Merck
Medicare's Plan to Negotiate Drug Discounts Won't Hit Pharma Hard, Analysts say
Expensive Drugs Targeted for First U.S. Price Negotiations
The Unexpected Bad News For Novo's Ozempic In Biden's Drug Negotiations List
First 10 Drugs Picked for Medicare Price Negotiations
Eliquis, Jardiance among first 10 drugs selected for Medicare price negotiations
Biden Administration to Reveal 10 Drugs for Which Medicare Will Pay Less
Merck Launches Phase 3 for MK-0616 Oral Cholesterol Drug >MRK
Merck, Eisai: Keytruda/Lenvima Combo Fails in Head, Neck Cancer Study
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.